CRIS Q3 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+3.5% YoY

Gross Profit

$3M99.2% margin

Operating Income

-$11M-360.5% margin

Net Income

-$10M-344.3% margin

EPS (Diluted)

$-1.70

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$42M

Total Liabilities

$51M

Stockholders' Equity

-$9M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+3.5%
Gross Profit	$3M	$3M	+4.9%
Operating Income	-$11M	-$12M	+14.6%
Net Income	-$10M	-$12M	+17.1%